Form 4: Cadre Holdings CEO and Chairman Warren B. Kanders Sells 100,000 Shares Under Pre-Arranged Plan

Sentiment:

Insider Transaction Report


Cadre Holdings, Inc.'s CEO and Chairman, Warren B. Kanders, reported the sale of 100,000 shares of common stock in two transactions totaling approximately $3.35 million, executed under a Rule 10b5-1 trading plan.

Summary

  • Warren B. Kanders, the CEO, Chairman, and a 10% owner of Cadre Holdings, Inc. (CDRE), reported the sale of 100,000 shares of the company's common stock.
  • The sales occurred in two separate transactions: 50,000 shares on June 18, 2025, at a weighted average price of $33.95 per share, and another 50,000 shares on June 20, 2025, at a weighted average price of $33.01 per share.
  • These transactions were conducted pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
  • The total value of the shares sold amounts to approximately $3,348,000.
  • Following these sales, Mr. Kanders' beneficial ownership includes 10,241,192 shares indirectly held by Kanders SAF, LLC (where he is the sole manager and member), 45,584 shares held directly, 1,305,650 shares indirectly held by Warren B. Kanders Roth IRA, and 23,450 shares indirectly held by Allison Kanders Roth IRA (his spouse).
  • The total remaining beneficial ownership after these transactions is 11,615,876 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant insider sale by the CEO and Chairman. However, the negative impact is mitigated by the fact that the sales were conducted under a pre-arranged 10b5-1 plan, suggesting they were not based on new, adverse information, and the insider retains a very substantial holding.

Positives

  • The sales were executed under a Rule 10b5-1 trading plan, which suggests the transactions were pre-scheduled and not based on new, non-public information, potentially mitigating negative market interpretations.
  • Despite the sales, Warren B. Kanders retains a very substantial beneficial ownership stake of over 11.6 million shares, indicating continued significant alignment with shareholder interests.

Negatives

  • The sale of 100,000 shares by a key insider (CEO, Chairman, and 10% owner) could be perceived by the market as a signal of reduced confidence or a belief that the stock is fully valued.
  • The average selling price for the second transaction ($33.01) was lower than the first ($33.95), indicating a slight decline in the stock price during the selling period.

Risks

  • Potential negative market sentiment: Insider selling, even under a 10b5-1 plan, can sometimes lead to negative investor perception and put downward pressure on the stock price.
  • Reduced insider alignment: While still substantial, the reduction in the CEO's direct and indirect holdings slightly decreases the overall alignment of management's personal wealth with the company's stock performance.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is an insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual's trading activity within the company's stock.

Related Party Transactions

  • Indirect beneficial ownership through Kanders SAF, LLC, where the Reporting Person is the sole manager and member.
  • Indirect beneficial ownership through Warren B. Kanders Roth IRA.
  • Indirect beneficial ownership through Allison Kanders Roth IRA, where Allison Kanders is the Reporting Person's spouse.

Stakeholder Impact

  • Shareholders: May interpret the insider sale as a signal, potentially influencing their investment decisions, although the 10b5-1 plan mitigates some concerns.
  • Employees: No direct impact mentioned, but general market perception could indirectly affect morale or confidence.

Key Dates

DateDescription
06/18/2025Date of first reported transaction (sale of 50,000 shares).
06/20/2025Date of second reported transaction (sale of 50,000 shares).
06/23/2025Date the Form 4 filing was signed.

Recommendation

hold

Keywords

Cadre Holdings, CDRE, Form 4, Insider Trading, Stock Sale, Warren B. Kanders, CEO, Chairman, Beneficial Ownership, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.